Scan to Download
One power score. Smarter investment decisions
Korro Bio Inc
KRRO33.220USD
+2.840+9.35%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
30.960USD+30.960After-hours 09/19, 20:00 (ET)
311.96MMarket Cap
LossP/E TTM
Korro Bio Inc
33.220
+2.840+9.35%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-31.76%-19.23M
-11.70%-24.45M
---7.50M
---16.09M
---14.59M
---21.89M
Net income from continuing operations
-18.07%-25.77M
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Operating gains losses
70.18%1.23M
68.73%1.23M
--1.25M
--865.00K
--721.00K
--726.00K
Other non-cash items
-90.63%88.00K
-115.13%-182.00K
---440.00K
---168.00K
--939.00K
--1.20M
Change in working capital
-31.65%3.15M
24.55%-3.87M
--11.18M
--2.94M
--4.61M
---5.13M
-Change in receivables
--835.00K
---228.00K
---1.70M
----
----
----
-Change in prepaid expenses
115.61%172.00K
-112.76%-617.00K
--167.00K
--499.00K
---1.10M
---290.00K
-Change in other current assets
-138.37%-33.00K
-572.09%-406.00K
--110.00K
--58.00K
--86.00K
--86.00K
-Change in other current liabilities
---371.00K
---626.00K
--9.43M
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-31.76%-19.23M
-11.70%-24.45M
---7.50M
---16.09M
---14.59M
---21.89M
Investing cash flow
Net cash from continuing investing activities
-97.65%140.00K
-97.88%119.00K
--1.45M
--4.88M
--5.96M
--5.61M
Capital expenditures
-97.65%140.00K
-97.88%119.00K
--1.45M
--4.88M
--5.96M
--5.61M
Net cash flow from disposal of fixed assets
-97.65%140.00K
-97.88%119.00K
--1.45M
--4.88M
--5.96M
--5.61M
Net cash flow from investment products
88.43%-11.16M
--32.90M
---1.31M
---7.70M
---96.43M
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
88.96%-11.30M
684.23%32.78M
---2.77M
---12.58M
---102.39M
---5.61M
Financing cash flow
Cash flow from continuous financing activities
-99.99%5.00K
23.74%172.00K
--932.00K
--728.00K
--67.56M
--139.00K
Net cash flow from common stock issuance/repurchase
----
----
--1.00K
--0.00
--67.38M
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
--0.00
--0.00
--0.00
Proceeds from stock option exercised by employees
-97.09%5.00K
23.74%172.00K
--931.00K
--728.00K
--172.00K
--139.00K
Net cash flow from other financing activities
----
----
--0.00
--0.00
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-99.99%5.00K
23.74%172.00K
--932.00K
--728.00K
--67.56M
--139.00K
Net cash flow
Beginning cash balance
-53.66%67.55M
-65.89%59.05M
--68.38M
--96.32M
--145.76M
--173.12M
Current period cash flow changes
38.23%-30.53M
131.07%8.50M
---9.33M
---27.94M
---49.43M
---27.36M
Effect of exchange rate changes
---9.00K
----
---6.00K
--2.00K
----
----
Ending cash balance
-61.57%37.02M
-53.66%67.55M
--59.05M
--68.38M
--96.33M
--145.76M
Free cash flow
5.77%-19.37M
10.66%-24.57M
---8.95M
---20.97M
---20.55M
---27.50M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
